Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865562 · ClinicalTrials.gov registry record · Phase 4
Hormones and Decision Making
A Phase 4 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT04865562: Completed Phase 4 study, sponsored by University of Texas at Austin.
NCT04865562 is a Phase 4 study that has completed, run by University of Texas at Austin. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04865562, a Phase 4 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
An investigation of the neuropsychological processes underlying ethical decision making.
Primary Outcome
drug administration following by behavioral outcome. Specifically, participants will have the opportunity to predict the outcome of a series of coin flips. To obtain a measure of ethical behavior, participants will have the opportunity to cheat by over-reporting their prediction accuracy.
Interventions
- DRUG testosterone propionate
- DRUG 0.5% cholorbutanol, saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2016-09-01 |
| Phase | Phase 4 |
What the finished NCT04865562 record still lists
NCT04865562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which testosterone propionate is the first listed.
NCT04865562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04865562 about?
NCT04865562 is a clinical study titled "Hormones and Decision Making". An investigation of the neuropsychological processes underlying ethical decision making.
What is the current status of trial NCT04865562?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2015-03-01. Estimated completion is 2016-09-01.
What interventions are being tested in trial NCT04865562?
The interventions under investigation include: testosterone propionate (DRUG), 0.5% cholorbutanol, saline (DRUG).
Who is sponsoring clinical trial NCT04865562?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04865562's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI